eISSN: 1937-8688

Fluoroquinolone-induced generalised fixed drug eruption: a rare clinical image

Sreeprada Bollineni, Gaurang Aurangabadkar

PAMJ. 2025; 50:56. Published 18 Feb 2025 | DOI: 10.11604/pamj.2025.50.56.45087

Fluoroquinolone-induced generalised fixed drug eruption: a rare clinical image
Fluoroquinolones are commonly used antimicrobial agents in patients presenting with respiratory diseases with levofloxacin, ofloxacin, and moxifloxacin having a significant role in the management of pulmonary tuberculosis and atypical pneumonia. However, the use of fluoroquinolones is also associated with the development of adverse drug reactions such as tendon rupture, Qtc interval prolongation, and generalised drug eruptions. Here we present to you a 70-year-old male patient who presented with generalised drug eruption rash over the body 3 days after starting levofloxacin therapy for atypical pneumonia. The patient was treated as per the dermatologist´s advice with oral corticosteroids and antihistaminics. After 7 days significant improvement was noted in skin eruptions. This clinical image aims to highlight a rare adverse effect of a commonly used antimicrobial agent.

Corresponding Author

Gaurang Aurangabadkar, Department of Respiratory Medicine, Datta Meghe Medical College, Nagpur, India (aurangabadkar712@gmail.com)

Article Formats

Articles published in Pan African Medical Journal are Open Access and distributed under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0).

Open Access Logo

The Pan African Medical Journal (ISSN: 1937-8688) is a product of the PAMJ. The contents of this journal is intended exclusively for professionals in the medical, paramedical and public health and other health sectors.